Hans-Dieter Volk, MD, is Professor of Immunology and head of the both Institute of Medical Immunology, Charité Berlin and BIH Center for Regenerative Therapies (BCRT) as well as deputy spokesman of the Berlin-Brandenburg School for Regenerative Therapies (BSRT) (all Berlin, Germany). In addition, he is scientific head of the division Immunology of the Labor Berlin Charité Vivantes GmbH, Berlin. His focus lies on implementation of new concepts in diagnosis and therapy of immunological diseases. Hans-Dieter Volk is an expert in coordinating and conducting clinical trials by biomarker development, monitoring new cell therapies, performing proof-of concept and investigator-initiated trials (all phase I/II). Moreover he was/ is co-editor/editorial board member of several high-impact journals (e.g. Am J Transpl, Transplantation) and board member of several scientific medicine societies (e.g. German Society Immunology, German Society Sepsis).
Scientific development: 1974-1980 Studies of Medicine, Berlin; 1982 M.D. (Dr. med.) Department of Immunology, Charité Berlin; 1987 Habilitation (PhD) and Senior Lecturer „Clinical Immunology“, Charité Berlin; since 1994 Head of Institute of Medical Immunology, C3 Professorship “Immunology”; since 2007 Head of BIH Center for Regenerative Therapies (BCRT) and W3 professorship; since 2009 Deputy spokesman of the Berlin-Brandenburg School for Regenerative Therapies (BSRT); since 2011 Head of the Div. Immunology, Labor Berlin Charité Vivantes GmbH
- Development of regenerative therapies (several BMBF grants, DFGSFB TR36, EU-FP7 “One Study”)
- Biomarker development and validation (EU-FP7: “Bio-DrIM” and “BioCog”, >40 industry-sponsored studies)
- Transplant immunology (DFG, foundation)
- Board member of several scientific societies and journals